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Abstract
Matching estimators for average treatment effects are widely used in the binary treatment
setting, in which missing potential outcomes are imputed as the average of observed outcomes
of all matches for each unit. With more than two treatment groups, however, estimation using
matching requires additional techniques. In this paper, we propose a nearest-neighbors match-
ing estimator for use with multiple, nominal treatments, and use simulations to show that this
method is precise and has coverage levels that are close to nominal. In addition, we implement
the proposed inference methods to examine the effects of different medication regimens on long-
term pain for patients experiencing motor vehicle collision.
Keywords: Causal inference; Generalized propensity score; Multiple testing; Nominal exposure;
Observational data.
1 Introduction
1.1 Overview
Many real-world applications of statistics involve comparison of multiple interventions or treat-
ments. Randomized experiments are the preferred scientific approach to obtaining an unbiased
comparison of two or more interventions. Multi-arm randomized experiments have been proposed
as an efficient experimental design to identify among multiple active interventions those that are sig-
nificantly better than a control treatment [1, 2]. In other cases, multi-arm randomized experiments
are used to identify the optimal active interventions [3]. When the design and implementation
of randomized experiments is untenable because of financial, logistical, or ethical considerations,
non-randomized observational studies can be used to compare the effectiveness of different inter-
ventions.
With continuous outcomes, a common practice is to conduct a “global test” to compare whether
one of the means is different. Only if the global test is rejected, additional analyses to identify
specific differences between the treatments are conducted [4, 5, 6]. Various estimands were proposed
to evaluate differences among multiple treatments in randomized experiments. Common estimands
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include all possible pairwise differences in means, all differences in means between the treatment
arms and the best treatment, all differences in means between active treatments and a control, and
all differences in means between the treatment arms and the overall mean [7]. In the context of
randomized experiments, many statistical procedures were developed to provide interval estimates
and hypothesis tests for these estimands (see [7] for references). These estimands are important in
comparative effectiveness research, because it is often insufficient to only examine a single hypothesis
of whether at least one of the treatments is different on average from the other treatments.
Non-randomized observational studies have been proposed as possible designs to compare the
effectiveness of multiple interventions for timely and urgent public health problems. For example,
each year nearly 4 million Americans are evaluated in emergency departments (ED) after expe-
riencing a motor vehicle collision (MVC) [8]. At the time of discharge from an ED, patients are
typically prescribed an opioid analgesic and/or a nonsteroidal antiinflammatory drug (NSAID) [9].
Prescribing of opioid analgesics has come under great scrutiny in the face of an ongoing epidemic
of opioid addiction. Thus, comparison of the effectiveness of multiple pain medications regimens
on chronic pain is a pressing public health issue. A similar type of public health issue requiring
pairwise comparisons was necessary to study the cost-effectiveness of case management for patients
with dementia [10], as well as to compare changes in coronary atheroma volume in patients receiving
high-intensity therapy, low-intensity statin therapy and no-statin therapy [11].
Because individuals were not randomized to interventions in observational studies, individuals
receiving one intervention may differ from those receiving another with respect to baseline covari-
ates. Matched sampling has been proposed to balance units on pre-intervention characteristics to
replicate the balance that would have occurred in randomized experiments. The theoretical basis of
matching to remove covariate bias was developed in the 1970s with papers by Cochran and Rubin
[12] and Rubin [13, 14], for settings with one covariate and two interventions. Matching procedures
are comprised of three main components: a distance measure between two units, the matching
algorithm, and the inference procedure for the matched cohorts. In this paper we provide inference
methods for matching methods when comparing multiple treatments in observational studies. We
apply the proposed methods to examine different pain medications regimens on long-term pain
after motor vehicle collisions.
1.2 Distance measures
When only a single covariate influences the assignment to treatment, it is often easy to identify
similar units. This task is more complicated as the number of covariates increases. With multiple
covariates and two treatment groups, the propensity score was proposed as a distance measure to
identify similar units [15].
The generalized propensity score [16] was proposed as a design tool to reduce the dimension
of the covariate space with multiple covariates and multiple nominal interventions. In contrast
to the propensity score, with Z > 2 interventions, the generalized propensity score is a vector of
Z − 1 dimensions, which complicates the task of identifying similar units. Generally, both scores
2
are unknown and are estimated from the observed data (see [17] and [18] for a review of estimation
methods). One possible estimation model for the generalized propensity score is the multinomial
logistic regression.
Other possible distance measures include the Euclidean or Mahalanobis distance on the original
covariates or on a function of the known or estimated generalized propensity scores. Once a distance
measure is defined, matching algorithms can be used to identify similar units.
1.3 Matching algorithms for multiple treatments
Lechner [19, 20] estimated the average treatment effects (ATE) for multiple treatments using a
series of binary comparisons. For each pair of treatments the method matches on the estimated
propensity score and separately estimates the average treatment effect for units receiving either of
these two treatments.
Common referent matching is a matching method for three treatments that creates sets with
one individual from each treatment group [21]. The treatment group with the smallest sample size
(say, group 1) is used as the reference group, and the propensity scores for treatment groups 1 and
2, and 1 and 3 are estimated separately using either logistic or probit regression models. Using 1:1
matching, pairs of units receiving treatments 1 or 2 are matched using the estimated propensity
score, and similarly for units receiving treatments 1 or 3. Only units receiving treatment 1 which
were matched to a unit receiving treatment 2 and to a unit receiving treatment 3, along with their
associated matches constitute the sample used for analyses.
An issue with a series of binary comparisons and common referent matching is that treatment
effect estimates only generalize to a subset of the population, rather than to the population of
units eligible to receive all of the available treatments. This may result in non-transitive treatment
effects, and prevents researchers from identifying the best treatment [18].
Vector matching is a greedy algorithm that uses k-means clustering and 1:1 nearest neighbor
matching to ensure that units matched on one component of the generalized propensity score vector
are well matched on all of the other components [18]. Vector matching relies on matching with
replacement and had the lowest covariate bias in matched sets, compared to other bias reduction
methods [18].
One issue with vector matching is its reliance on greedy matching, which may not be the most
optimal procedure to reducing covariate bias among all treatments. With binary treatment, algo-
rithms like full matching [22], which relies on network flow theory, and mixed integer programming
[23] were proposed to optimally match units such that the difference in the covariates’ distribu-
tions between the two treatment groups is minimized while retaining most of the units. Optimally
matching for multiple treatments, also known as k-dimensional matching, was shown to be a NP-
hard problem [24]. The computational complexity of such methods may make them impractical in
problems with many units and multiple treatments.
3
1.4 Inference procedures
For two treatments, the statistical literature include several procedures for point and interval esti-
mates for the ATE with matched units. Generally, point estimates from matched units are obtained
using similar procedures that are applied to entire datasets [17]. Interval estimation has been de-
bated in the literature. Randomization based standard errors have been shown to underestimate
the true standard error, resulting in statistically invalid interval estimates [25, 26, 27]. For 1:1
matching with replacement, Hill and Reiter [26] proposed to use the Hodges-Lehmann aligned rank
test when the treatment effect is additive, and when the treatment effect is not additive, they pro-
posed a non-parameteric bootstrap algorithm for standard error estimates. When estimating the
ATE, Abadie and Imbens [28] showed that for matching with replacement the bootstrap method
may be invalid in certain situations, and suggested using the formula derived in [25] for estimating
the standard error. For matching without replacement, Austin and Small [29] proposed a non-
parametric bootstrap procedure for estimating the ATE after propensity score matching. Using
simulations, they showed that estimates of the standard error using this procedure were close to
the empirical standard deviation of the sampling distribution of the estimated effects. For multiple
treatments, Rassen et al. [21] relied on sampling variance estimates that ignore the variability in
the matching procedure. As in the binary case, this estimate may underestimate the standard
error.
Non-matching estimation methods for binary and multiple treatments include linear regression
adjustments, inverse probability weighting, and doubly robust methods [30]. For binary treatment,
adjusting for covariate imbalances using linear regression adjustment has been found to be generally
biased for estimating ATEs, and are only approximately unbiased when the two response surfaces
are nearly linear and parallel [14]. Gutman and Rubin [27, 31] found that both inverse probability
weighting and doubly robust estimation resulted in generally valid procedure for binary treatment,
though each of these methods is susceptible to extreme weights which can yield erratic causal
estimates. This phenomenon is exacerbated with an increasing number of treatments and covariates
that are not normally distributed [18]. McCaffrey et al. [30] proposed to apply a sandwich estimator
in combination with generalized boosted models to estimate the generalized propensity scores to
obtain individual point and interval estimates for pairwise ATEs.
Yang et al. [32] proposed matching and subclassification estimates for estimating pairwise
average treatment effects with multiple treatments. However, they did not provide an overall
global test for the any difference between the outcomes, and they only describe an estimation
procedure for the average differences over the entire population.
Abadie and Imbens provided an empirical formula for variance estimation of matching esti-
mators for binary treatment [25] and proposed a bias-corrected matching estimator that yielded
consistent point estimates when there was more than one continuous covariate [33]. We extend
the work of Abadie and Imbens [25, 33] by deriving super-population point and interval estimates
for the vector of the pairwise average treatment effects when comparing more than two treatments
and using matching with replacement procedures. Our procedure enables to perform a global hy-
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pothesis test as well as derivation of individual point and interval estimates for all pairwise ATEs
and pairwise average treatment effects among those receiving a specific treatment (average treat-
ment effect on the treated, [18], [30]). We show that this method is generally valid and produces
estimates that are relatively accurate and precise.
2 Notation for multiple treatments
For Z possible treatment groups, let Wi denote the treatment group identification for unit i, where
Wi ∈ W = {1, . . . , Z} and i = 1, . . . , n < ∞. Let nw be the sample size of treatment group w
such that
∑Z
w=1 nw = n. We define Tiw, w ∈ {1, . . . , Z}, to be an indicator variable for each
unit i, i = 1, . . . , n, that is equal to 1 if Wi = w and to 0 otherwise. Thus, unit i has a set of
indicator variables, {Ti1, . . . , TiZ}, where only TiWi = 1 and the rest of the indicators are equal
to zero. Let Yi = {Yi(1), . . . , Yi(Z)} be the set of potential outcomes for unit i, where Yi(w) is
the potential outcome for unit i if it was exposed to treatment w. In practice, only the potential
outcome corresponding to the intervention that affected unit i is observed. The other potential
outcomes cannot be observed because they correspond to treatment assignments that did not occur
[34, 35]. Assuming the Stable Unit Treatment Value Assumption [36], the observed outcome for
unit i can be written as Y obsi = Ti1Yi(1) + · · · + TiZYi(Z). Because we cannot directly observe
the causal effect for unit i, we need to rely on multiple units of which some are exposed to each
of the other Z − 1 possible treatments. For drawing causal inference there are variables that are
unaffected by Wi: covariates Xi = (Xi1, . . . , XiP ) ∈ X.
With Z treatments, possible estimands of interest are the pairwise population average treatment
effects between treatments j and k, τjk = E (Y (j)− Y (k)), for (j, k) ∈ W2 and j 6= k [18]. A
possible extension of τjk would be to contrast treatments among a subset of units in the population
receiving baseline treatment t ∈ W and obtain the population average treatment effect on the
treated [30], τ tjk = E (Y (j)− Y (k) |W = t), for (j, k) ∈ W2 and j 6= k.
The estimands τjk and τ
t
jk can be approximated using the sample average treatment effects:
τˆjk =
1
n
n∑
i=1
(Yi(j)− Yi(k)) , τˆ tjk =
1
nt
n∑
i=1
Tit (Yi(j)− Yi(k)) .
Because only one of Yi(w), w ∈ W is observed, matching procedures were proposed to impute the
unobserved potential outcomes. For the remainder of the article, we will focus on estimating τ tjk.
In the Supplementary Material we present the corresponding results for τjk.
We assume the following convenient regularity condition:
Assumption 1 : Xi is a random vector of continuous covariates distributed on RP with compact
and convex support X, with density bounded away from zero on its support.
Although Assumption 1 requires that all of the variables in X have a continuous distribution,
discrete covariates with a finite number of support points can be accommodated by estimation of
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the treatment effects within subsamples defined by the values of these variables.
A crucial piece of information that is needed for causal effect estimation is the assignment
mechanism, or in other words, the probability for each unit to receive one of the Z treatments,
P (Wi = w | Xi,Yi):
Assumption 2 : Strong unconfoundedness and overlap [18]
i. P (Wi = t | Xi,Yi, φ) = P (Wi = t | Xi, φ) ≡ r(t,X), where φ is a vector of parameters
controlling the conditional distribution of Wi = t and is notationally suppressed in
r(t,X).
ii. r(t,X) < 1− η for all w ∈ W and some 0 < η < 1.
Under strong unconfoundedness, comparing individuals with similarR(X) = (r(1, X), . . . , r(Z,X))
results in well-defined causal effects [16]. Commonly, R(X) is unknown and only an estimate of it
is available, Rˆ(X) = (rˆ(1, X), . . . , rˆ(Z,X)).
Because treatment groups may be sampled separately and their sample sizes may not be pro-
portional to their sizes in the population, we assume that sampling is random conditional on Wi.
We also assume that each nw, w 6= t, is at least the same order of magnitude as nt. Formally:
Assumption 3 : Conditional on Wi = w, the sample consists of independent draws from
Y,X |W = w for w ∈ W. For some r ≥ 1, nrt/nw → ρ with 0 < ρ <∞.
We also assume regularity conditions on the conditional moments of Y (w) | X,W :
Assumption 4 : For covariates x ∈ X and treatment w ∈ W, define µw(x) = E(Y (w) | X = x)
and σ2w(x) = V ar(Y (w) | X = x) = V ar(Y | X = x,W = w). Then, (i) µw(x) and σ2w(x) are
Lipschitz in X for all w ∈ W, (ii) E[(Yi(w))4 | Xi = x] ≤ C for some C < ∞, for almost all
x ∈ X, and (iii) σ2w(x) is bounded away from zero.
3 The matching estimator
3.1 Point estimates
For a vector x ∈ X, let ||x||A = (x′Ax)1/2 for some positive definite matrix A. For example, when
A is the identity matrix this measure is the Euclidean distance. Our derivations will focus on
matching with replacement, such that each unit can be used as a match more than once, and on
the distance measure between units i and j of the form ||Xi−Xj ||A. When matching on continuous
covariates, matches are usually inexact, which generates bias in matching estimators. Matching
with replacement increases the set of possible matches, which typically produces smaller biases [25].
LetMwi denote the set of indices for the “closest” m units to unit i that were exposed to treatment
w 6= Wi, and nw ≥ m for all w. Formally,
∑
j:Wj=w
I{||Xj −Xi|| ≤ ||Xl∈MWi −Xi||} = m, where I
is an indicator function, , equal to 1 if the expression in brackets is true and zero otherwise.
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The matching estimator imputes the missing potential outcomes as the average of the m ob-
served outcomes of the units in Mwi ,
Yˆi(w) =
Y obsi , Tiw = 11
m
∑
j∈Mwi Y
obs
j , Tiw = 0.
Let ψiw =
∑
Wj=w
I{i ∈ MWij } be the number of times that unit i serves as a match to other
units in treatment group w, with ψiWi = 0. The point estimate for τ
t
jk is
τˆ tjk =
1
nt
∑
Wi=t
(
Yˆi(j)− Yˆi(k)
)
=
1
nt
n∑
i=1
(Tij − Tik)
(
Tit +
ψit
m
)
Y obsi ,
We define τ t = {τ tjk : j ∈ W, k ∈ W, j < k} and its point estimate τˆ tM = {τˆ tjk : j ∈ W, k ∈ W, j <
k}. The point estimate for τjk can be obtained by summing the τˆ tjks of all reference groups t,
weighted by their respective shares in the sample (see Supplementary Material).
The expectations of the potential outcomes are estimated by the sample averages,
Y˜ t(w) ≡ 1
nt
∑
Wi=t
Yˆi(w) =
1
nt
n∑
i=1
Tiw
(
Tit +
ψit
m
)
Y obsi .
Let µtw = E(µw(X) | W = t). We can decompose the bias Y˜ t(w) − µtw into the following three
parts [25]:
Y˜ t(w)− µtw =
(
µw(X)− µtw
)
+Btw + E
t
w,
where µw(X) ≡ 1nt
∑n
i=1 Titµw(Xi),
Btw ≡
1
nt
n∑
i=1
Tit(1− Tiw)
m
∑
j∈Mwi
(µw(Xi)− µw(Xj))
 , Etw ≡ 1nt
n∑
i=1
Tiw
(
Tit +
ψit
m
)
iw,
and iw = Yi(w) − µw(Xi). The terms
(
µw(X)− µtw
)
and Etw each have zero mean, and are
asymptotically normal (see Section 3.5).
If the number of continuous covariates P ≥ 1, then the conditional bias term Btw is in general
not n1/2 consistent. Though if the parameter of interest is τ tjk, the bias can be ignored if each nw,
w 6= t, is of sufficient order of magnitude [25].
3.2 Bias-corrected point estimates
To reduce the bias in point estimation that is a consequence of matching on a large number of
covariates or when treatment t is over-sampled relative to treatment w 6= t, we propose a regression
imputation method. Let µˆw(x) be a consistent estimator of µw(x). The bias-corrected matching
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estimator is
Yˆ bci (w) =
Yi(w), Tiw = 11
m
∑
j∈Mwi (Yj(w) + µˆw(Xi)− µˆw(Xj)) , Tiw = 0.
A possible estimate for µˆw(Xi) is Eˆ(Y
obs
i |Xi,Wi, βw) in each of the Z treatment groups, estimated
using multiple linear regression including all pretreatment covariates and possible second-order
interactions. These estimators were shown to be robust to the misspecification of the regression
function and are n1/2 consistent, when using a nonparametric series estimator for µw(x) [33]. Let
τˆbc,tM be τˆ
t
M with Yˆi(w) replaced by Yˆ
bc
i (w), and let
Bˆtw =
1
nt
n∑
i=1
Tit(1− Tiw)
m
∑
j∈Mwi
(µˆw(Xi)− µˆw(Xj))
 .
The bias corrected matching estimator for τ tjk is τˆ
bc,t
jk = τˆ
t
jk − (Bˆtk − Bˆtj). Based on Theorem 2’ in
Abadie and Imbens [33], τˆbc,tM has the same asymptotic variance as τˆ
t
M .
3.3 Sampling variance
In order to calculate the marginal sampling variance of τˆ tM , it is useful to decompose it into a linear
combination of the vector Y˜ t = (Y˜ t(1), . . . , Y˜ t(Z)), such that
τˆ tM =

1
nt
∑
Wi=t
(
Yˆi(1)− Yˆi(2)
)
1
nt
∑
Wi=t
(
Yˆi(1)− Yˆi(3)
)
...
1
nt
∑
Wi=t
(
Yˆi(Z − 1)− Yˆi(Z)
)
 =

1 −1 0 · · · 0 0
1 0 −1 · · · 0 0
...
...
...
. . .
...
...
0 0 0 · · · 1 −1


Y˜ t(1)
Y˜ t(2)
...
Y˜ t(Z)
 = AY˜ t.
Lemma 1. If Assumption 3 holds, then Y˜ t(w) and Y˜ t(w′) are independent for all w 6= w′.
(Proof: see Supplementary Material.)
Based on Lemma 1, Cov(Y˜ t(w), Y˜ t(w′)) = 0 for w 6= w′, thus for j 6= k 6= l:
Cov(Y˜ t) = diag
(
V ar(Y˜ t(1)), . . . , V ar(Y˜ t(Z))
)
,
Cov(τˆ tjk, τˆ
t
jl) = V ar(Y˜
t(j))
V ar(τˆ tM ) = A{Cov(Y˜ t)}AT
Using the law of total variance, the marginal variance of Y˜ t(w) can be expressed as
V ar(Y˜ t(w)) =
E{ntV ar(Y˜ t(w) | X,W )}+ V ar(µw(X))
nt
, (1)
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where
V ar(Y˜ t(w) | X,W ) = 1
n2t
n∑
i=1
Tiw
(
Tit +
ψit
m
)2
σ2Wi(Xi). (2)
Using Equations 1–2, and the derivations given in Abadie and Imbens [25], pages 250-251, the
estimated marginal variance of τˆ tjk is
V̂ ar(τˆ tjk) =
1
n2t
∑
Wi=t
(
Yˆi(j)− Yˆi(k)− τˆ tjk
)2
+
1
n2t
n∑
i=1
(Tij + Tik)
(
ψit(ψit − 1)
m2
)
σˆ2Wi(Xi),
where σˆ2Wi(Xi) is an estimate of the conditional outcome variance, σ
2
Wi
(Xi).
Abadie and Imbens [25] showed that, with binary treatment, V̂ ar(τˆ112) is consistent. The fol-
lowing theorem shows that the estimated marginal covariance between τˆ tjk and τˆ
t
jl is consistent for
V ar(Y˜ t(j)).
Theorem 1. Let σˆ2Wi(Xi) be an estimate of the conditional outcome variance, σ
2
Wi
(Xi). Then
Ĉov(τˆ tjk, τˆ
t
jl) = V̂ ar(Y˜
t(j)) =
1
n2t
∑
Wi=t
(
Yˆi(j)− Y˜ t(j)
)2
+
1
n2t
n∑
i=1
Tij
(
ψit(ψit − 1)
m2
)
σˆ2Wi(Xi).
If Assumptions 1–4 hold, then V̂ ar(Y˜ t(j)) is consistent for V ar(Y˜ t(j)).
(Proof: see Supplementary Material.)
Because Ĉov(τˆ tjk, τˆ
t
jl) is consistent for V ar(Y˜
t(j)), it follows that we can consistently estimate
Cov(Y˜ t). Therefore, we can consistently estimate V ar(τˆ tM ) using a matrix consisting of marginal
variances of the Y˜ t(j)s.
3.4 Estimating σ2w(X)
For binary treatment, Abadie and Imbens [25] developed a procedure that estimates σ2w(X) by
matching unit i in treatment group w to the closest unit(s) in treatment group w, in terms of the
propensity score. We extend this procedure by finding units with similar R(X).
Let Lwi be the set of matches for unit i from its own treatment group w, excluding unit i itself.
Let dˆ(w,X) = log
(
rˆ(w,X)
rˆ(Z,X)
)
and Dˆ(X) = (dˆ(1, X), . . . , dˆ(Z,X)). When R(X) is estimated using
multinomial logistic regression, dˆ(w,X) is a linear combination of X, γˆ′X. We define the distance
between two units to be the Euclidean distance of Dˆ(X):
∑
w∈1,...,Z−1 {logit(rˆ(w,Xi′))− logit(rˆ(w,Xi))}2,
where i′ = 1, . . . , nw and i 6= i′.
When |Lwi | = J , σ2w(Xi) can be estimated by
σˆ2w(Xi) =
J
J + 1
Y obsi − 1J
J∑
j=1
Y obs`wj (i)
2 ,
where `wj (i) is the index of the jth closest match to unit i from treatment group w.
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If the covariate values for unit i are equal to the covariate values of all units in Lwi , then σˆ2w(Xi)
is an unbiased estimate of σ2w(Xi). However, it is not a consistent estimate for σ
2
w(Xi), though
appropriately weighted averages of the σˆ2w(Xi) over the sample are consistent for V ar(Y˜ (w) | X,W )
and ntV ar(Y˜
t(w) |W,X) [25].
Generally, the covariate values differ between units. Imbens and Rubin [37] proposed a bias
corrected version of σˆ2w(Xi) for binary treatment settings. The procedure relies on the regression
model E(Y obsi | Xi,Wi = w) = Xiβw for each treatment group, and σˆ2w(Xi) is estimated by the
variance of the residuals obtained from these regression models for unit i and its J closest matches.
A similar method can be implemented for multiple treatments, by estimating separate regression
models in each of the Z treatment groups.
3.5 Asymptotic normality
We state the formal result for asymptotic normality of the Y˜ t(w)s after subtracting the conditional
bias term.
Theorem 2.
i. Suppose Assumptions 1–4 hold. Then
[V ar(Y˜ t(w))]−1/2
(
Y˜ t(w)−Btw − µtw
)
→ N(0, 1),
and [V ar(τˆ tM )]
−1/2(τˆ tM −BtM − τ t)→ Np(0, Ip).
ii. Suppose Assumptions 1–4 hold. Then under several additional regularity conditions (see
Supplementary Material),
[V ar(Y˜ t(w))]−1/2
(
Y˜ bc,t(w)− µtw
)
→ N(0, 1),
and [V ar(τˆ tM )]
−1/2(τˆ bc,tM − τ t)→ Np(0, Ip).
(Proof: see Supplementary Material.)
Based on Theorem 3.3,
z2 = (τˆ tM −BtM − τ t)T[V ar(τˆ tM )]−1(τˆ tM −BtM − τ t) ∼ χ2p,
and a 100(1− α)% confidence region is the region such that P (z2 ≤ χ2p) = 1− α [38].
10
3.6 Weighting Estimators
Inverse probability weighting (IPW) is another common approach for estimating causal effects with
multiple treatments [30, 38, 39]. Under weak unconfondedness [40], τ tjk can be estimated as
τˆ t,IPWjk = E(Yˆi(j))− E(Yˆi(k))
=
( n∑
i=1
I(Wi = j)Y obsi r(t,Xi)
r(j,Xi)
)
×
(
n∑
i=1
I(Wi = j)r(t,Xi)
r(j,Xi)
)−1
−
( n∑
i=1
I(Wi = k)Y obsi r(t,Xi)
r(k,Xi)
)
×
(
n∑
i=1
I(Wi = k)r(t,Xi)
r(k,Xi)
)−1 . (3)
Because R(X) is commonly unavailable, it is replaced by Rˆ(X) in Equation 3. Thus, in order to
calculate the sampling variance of this estimate, the sandwich estimator, which takes into account
the uncertainty in the estimated propensity score, is commonly implemented [30, 38].
The consistency of IPW estimates relies on the correct specification of the GPS model. A “dou-
bly robust” estimator attempts to overcome this limitation by combining weighting with regression
adjustments. Formally, E(Yˆi(j)) in Equation 3 is replaced by n
−1∑n
i=1
(
TijY
obs
i
r(j,Xi)
− (Tij−r(j,Xi))r(j,Xi) µˆw(Xi)
)
.
The “doubly robust” estimator yields consistent estimates of the treatment effect if either the
model for the outcome or the propensity score model is correct, but not necessarily both [41].
4 Simulations
4.1 Evaluating coverage of matching estimator by simulation
We examined the operating characteristics of the different procedures in finite samples, using sim-
ulations. The derivations in Section 3 are limited to a specific matching algorithm that relies on
the ||Xi −Xj ||A distance measure between units i and j. Thus, we examined the performance of
the matching estimators using either the vector matching algorithm [18] or a matching algorithm
that is based on the Mahalanobis distance of the logit GPS vector [42]. Because both matching
algorithms yielded similar results, we provide the results for vector matching in the manuscript and
the results for matching on the Mahalanobis distance of the logit GPS vector are described in the
Supplementary Material (Table 1). The simulations were conducted using the Matching package
[43] in R Studio [44].
The performance of the different matching estimators were compared using a complete factorial
design. The simulation configurations comprise two types of factors. The first set of factors
describes the covariate distributions and sample sizes, which are either known to the investigator,
or can be easily estimated without examining outcome data. The second set of factors involves the
response surfaces which are unknown to the investigator and cannot be estimated at the design
stage. The covariates’ values of the n1, n2 = γn1, and n3 = γ
2n1 units receiving treatments 1, 2,
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and 3, respectively, are generated from multivariate normal or multivariate t7 distributions:
Xi | {Wi = 1} ∼ f(µ1,Σ1), i = 1, . . . , n1,
Xi | {Wi = 2} ∼ f(µ2,Σ2), i = n1 + 1, . . . , n1 + γn1,
Xi | {Wi = 3} ∼ f(µ3,Σ3), i = n1 + γn1 + 1, . . . , n1 + γn1 + γ2n1,
where f ∈ {N, t7}, and
µ1 = ((b, 0, 0), . . . , (b, 0, 0))
T,
µ2 = ((0, b, 0), . . . , (0, b, 0))
T,
µ3 = ((0, 0, b), . . . , (0, 0, b))
T.
The covariance matrices Σ1, Σ2, and Σ3 have respective diagonal entries of 1, σ
2
2, and σ
2
3, and λ
elsewhere. Additionally, we examined configurations in which Xi3 and Xi6 were converted to binary
variables, such that Xip = 1 if Xip > 0 and 0 otherwise, p ∈ {3, 6}.
For each configuration of the design factors, we generate the potential outcomes as Yi(w) =∑P
p=1 g(Xip)
Tβwp + w,i, where βwp
iid∼ Uniform(−θ, θ), and w,i ∼ N(0, 1) for i = 1, . . . , n. These
response surfaces imply that the treatment effects are correlated with X and are non-additive.
Table 1: Simulation factors
Factor Levels of factor
n1 {600, 1200}
γ = n2n1 =
n3
n2
{1, 2}
b B = b√
1+σ22+σ
2
3
3
takes levels {0, 0.25, 0.50, 0.75, 1.00}
λ {0, 0.25}
σ22 {0.5, 1, 2}
σ23 {0.5, 1, 2}
θ {2, 5, 10}
P {3, 6}
f {N, t7}
g {X, exp(X/10)}
The distributions of X and Y (w) are varied by ten factors, resulting in a 26 × 33 × 5 facto-
rial design (Table 1). For each configuration, 500 replications were produced. We evaluate the
performance of the basic (Section 3.1) and bias-corrected (Section 3.2) point estimates, and their
combination with the newly proposed standard error (Section 3.3) and with randomization based
standard error [45]. We denote these as B-N, BC-N, B-R, and BC-R, where B stands for the basic
point estimate, BC stands for the bias-corrected point estimate, and N and R stand for the newly
proposed and the randomization based standard errors, respectively. For all matching procedures,
we used m = 1, and for estimating the conditional outcome variance we assumed that J = 1.
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We also evaluate the performance of inverse probability weighting (IPW) and doubly robust
(DR) estimators [30], which estimate each τ1jk separately. For each replication, we calculated the
estimated treatment effects, the estimated sampling covariance matrices, the corresponding 95%
confidence regions and 95% Bonferroni-adjusted pairwise confidence intervals [46], and determined
whether these regions and intervals covered the treatment effects. Results for configurations with
only continuous covariates show similar trends and are reported in the Supplementary Material
(Table 2).
4.2 Results for 95% region and interval coverages
Using simulations, we demonstrate that the basic and bias-corrected point estimates, in combination
with the newly proposed sampling variance estimate, result in statistically valid methods, while a
combination of these point estimates with randomization based sampling variance are generally in-
valid. Table 2 displays the median and interquartile range of the coverages, with confidence regions
as well as using Bonferroni-corrected pairwise intervals. The basic and bias-corrected matching
estimators with the proposed standard error estimates (B-N and BC-N) have median confidence
region coverages that are at or higher than nominal. The basic and bias-corrected matching esti-
mators with randomization based standard error estimates (B-R and BC-R) have median coverage
region that is less than 0.75 for a 95% confidence region.
Table 2: Median, 25% percentile, and 75% percentile of the 95% region coverage for τ1, and the 95%
interval coverage for τ1jk averaged over three estimands (B: basic point estimate; BC: bias-corrected
point estimate; N: newly proposed standard errors; R: randomization based standard errors; IPW:
inverse probability weighting; DR: doubly robust estimation)
Confidence Region Confidence Interval
Median 25% 75% Median 25% 75%
B-N 0.95 0.78 0.98 0.96 0.86 0.98
BC-N 0.97 0.87 0.99 0.98 0.92 0.99
B-R 0.70 0.33 0.88 0.81 0.57 0.92
BC-R 0.75 0.34 0.91 0.86 0.62 0.95
IPW – – – 0.85 0.57 0.95
DR – – – 0.85 0.57 0.94
B-R, BC-R, IPW, and DR, have median interval coverage that is lower than nominal. Among
these methods, the 25th percentile of coverage is the highest for BC-N. B-N and BC-N have median
interval coverages that are at or greater than nominal.
To identify the factors with the largest influence on the coverage for each of the methods,
we order them by their mean squared error for coverage rate (as in [47] and [48]). The number of
covariates (P ), the ratio of units receiving W = 2 to those receiving W = 1 (γ), the initial covariate
bias (b), and their interactions explain 61%, 58%, 83%, and 70% of the variability in coverage for
B-N, BC-N, B-R, and BC-R, respectively. For IPW and DR, b and γ explained 32% and 29% of
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the variability in coverage, respectively. The number of covariates P was not as influential when
using IPW or DR.
Table 3: Median region coverage for equal and unequal sample sizes
B-N BC-N B-R BC-R
b P = 3 P = 6 P = 3 P = 6 P = 3 P = 6 P = 3 P = 6
γ = 1
0.00 0.97 0.98 0.98 0.99 0.89 0.89 0.90 0.93
0.25 0.96 0.94 0.98 0.97 0.77 0.73 0.79 0.76
0.50 0.93 0.86 0.96 0.94 0.56 0.43 0.51 0.48
0.75 0.87 0.77 0.93 0.88 0.32 0.23 0.23 0.24
1.00 0.77 0.65 0.87 0.82 0.14 0.10 0.08 0.09
γ = 2
0.00 0.97 0.98 0.97 0.99 0.95 0.94 0.96 0.96
0.25 0.93 0.98 0.96 0.99 0.87 0.92 0.91 0.95
0.50 0.83 0.98 0.90 0.99 0.69 0.84 0.78 0.90
0.75 0.72 0.97 0.78 0.99 0.45 0.67 0.51 0.77
1.00 0.55 0.96 0.65 0.99 0.22 0.50 0.25 0.57
We further detail the effects of the principal determinants of coverage by averaging over the
other factors. Table 3 shows the median region coverage for the newly proposed methods based on
b, P , and γ. In settings with γ = 1 and P = 3, B-N and BC-N have median coverages that are at or
above nominal across all levels of b. In settings with γ = 1 and P = 6, B-N and BC-N have median
coverages that are at or above nominal for b ≤ 0.5, and lower than nominal when b > 0.5. The latter
configurations are hard cases for matching estimators [47]. Both point estimates with randomization
based sampling variance have close to nominal coverage only when the covariate distributions are
similar across treatment groups (b = 0.00), which is practically a randomized experiment. Median
coverages are higher than nominal for B-N and BC-N when γ = 2. Median coverages for IPW or
DR were lower than nominal for b ≥ 0.25 and t-distributed continuous covariates (data in Table 3
of Supplementary Material).
4.3 Results for biases and interval widths
The bias-corrected matching estimator has the lowest bias, and weighting methods have the largest
biases for b > 0. The first part of Table 4 depicts the median absolute biases for the basic, bias-
corrected, IPW, and DR point estimates across the levels of b. Because there are three point
estimates, we calculated the overall bias by averaging the absolute bias of each of the three point
estimates for each configuration, and then estimated the median across configurations and levels
of b. When b increases, the median overall absolute bias increases for all of the methods, with the
bias-corrected point estimate having the smallest bias. For IPW and DR, the median and IQR
absolute biases increase faster with b, and for b ≥ 0.50, they are over double the size of the biases
obtained for the basic matching estimator.
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Table 4: Median absolute bias, interval width, and ratio of the newly proposed, randomization
based, IPW, and DR standard errors to the empirical standard errors averaged over the three
estimates, across 8,640 configurations (parentheses are the interquartile range)
b
Method 0.00 0.25 0.50 0.75 1.00
Bias B 0.03 (0.04) 0.07 (0.16) 0.12 (0.32) 0.19 (0.52) 0.27 (0.78)
BC 0.03 (0.04) 0.06 (0.16) 0.11 (0.30) 0.17 (0.48) 0.25 (0.70)
IPW 0.02 (0.03) 0.10 (0.26) 0.19 (0.51) 0.29 (0.79) 0.38 (1.04)
DR 0.02 (0.03) 0.09 (0.25) 0.18 (0.51) 0.28 (0.78) 0.39 (1.08)
Interval N 0.63 (1.37) 0.64 (1.42) 0.75 (1.66) 0.92 (1.97) 1.20 (2.46)
Width R 0.49 (1.13) 0.47 (1.08) 0.47 (1.10) 0.49 (1.14) 0.52 (1.22)
IPW 0.38 (0.84) 0.41 (0.91) 0.53 (1.19) 0.79 (1.83) 1.18 (2.84)
DR 0.37 (0.77) 0.40 (0.83) 0.51 (1.05) 0.74 (1.60) 1.07 (2.40)
SE N 1.02 1.04 1.05 1.05 1.06
Ratio R 0.81 0.76 0.67 0.55 0.45
IPW 1.13 1.14 1.16 1.07 0.96
DR 1.10 1.12 1.14 1.08 0.99
The second part of Table 4 depicts the median interval width using the newly proposed and
the randomization based sampling variances, IPW and DR, across levels of b. We used Bonferroni
correction to obtain the three 95% pairwise confidence intervals for each configuration, and we
examined the median of the average of the three interval widths for all configurations across the
levels of b. The median interval widths are overall larger for the newly proposed standard errors
than for the randomization based standard errors. However, the randomization based standard
errors generally result in invalid statistical procedures. For IPW and DR, the median and IQR
interval widths are smaller for b ≤ 0.50, and increase sharply for larger b.
The newly proposed sampling variance estimates approximate the empirical sampling variance
well. We calculated the average of the ratios of the randomization based and newly proposed
standard errors of τˆ112, τˆ
1
13, and τˆ
1
23, to their empirical standard errors for each configuration, and
did the same for the IPW and DR standard errors. The medians of the ratios for the newly
proposed, IPW, and DR standard errors are close to 1 for all levels of b. These findings imply
that the these standard error estimates provide good approximations to the empirical ones, and
the poorer coverage rates for IPW and DR stem from large biases as a result of increasing b. The
medians of these ratios for the randomization based standard errors are smaller than 1, implying
that they underestimate the standard errors.
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5 Real data application
5.1 Emergency department data
We compare the effects of different pain medication regimens on long-term pain among patients
that were discharged from the emergency department (ED) after motor vehicle collision (MVC).
The data were collected as part of two large, multicenter, prospective cohort studies of adult pa-
tients who presented to an ED within 24 hours of a MVC and were discharged to home after
evaluation [49]. Here, we examined three medication regimens: opioid analgesic, non-steroidal
anti-inflammatory drugs (NSAIDs), and a combination of both. The primary outcome was the self-
reported overall pain severity six weeks after the MVC, which was assessed using a 0 to 10 numeric
rating scale. GPS models were fit using multinomial logistic regression that included demographics
characteristics, accident characteristics, initial pain, clinical characteristics and comorbidities. The
pre-matched cohort included 257 patients that were prescribed opioids, 951 patients that were pre-
scribed NSAIDs, and 110 patients that were prescribed both. Because some of the baseline covari-
ates and the outcome suffered from missing values we created 20 multiple complete datasets using
the fully conditional specification approach in each arm separately [50]. Each complete dataset was
analyzed separately using the proposed approach and the results were combined using the common
combination rules [51]. The multiple imputation procedure was performed using the mice package
in R [52]. This analysis practically assumes that missing outcomes are not differentially missing
across treatment arms and that they are not influenced by the unobserved potential outcomes.
These are strong assumptions that should generally be examined using sensitivity analyses.
Matching quality was assessed using diagnostics presented in McCaffrey et al. [30], Lopez and
Gutman [18], and Scotina and Gutman [42], for all of the imputed datasets. Vector matching
retained 96% of reference treatment patients in the matched cohort, and yielded a maximum
absolute covariate pairwise bias of 0.29, as compared to 0.46 in the pre-matched cohort. Figure 1
reports the maximum absolute standardized pairwise bias, Max2SBp, for each of 18 of the baseline
covariates in the original, unmatched sample, and for the matched sample for one of the imputed
datasets. Vector matching yielded improved balance for most of the covariates. Results are similar
for each imputed dataset (data not shown).
We performed simultaneous comparison across the three estimates by combining the χ2 statistics
across the 20 multiply imputed datasets [53]. For B-N we obtained χ2 = 0.18 and p-value = 0.91,
and for BC-N we obtained χ2 = 0.11 and p-value = 0.95. Thus, at the 5% level, we are unable
to reject the global null hypothesis of similar pain levels six weeks after MVC between the three
medication regimens. Figure 2 displays the estimated pairwise average treatment effects between
patients receiving opioids versus NSAIDs, and opioids versus concurrent treatment with opioids and
NSAIDs, among patients receiving opioids, using the B-N, BC-N, IPW, and DR. The estimated
difference in reported pain severity 6 weeks after the MVC between opioid and NSAID users using
BC-N was 0.07 with 95% confidence interval (−0.56, 0.70), similar results were observed for the
other methods, with DR having the shortest interval . The estimated difference in reported pain
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Figure 1: Max2SBp for the pre-matched cohort and after vector matching
severity 6 weeks after the MVC between opioid and concurrent opioid and NSAID users using BC-
N was 0.20 with 95% confidence interval (−0.83, 1.23), with similar results observed for the other
methods.
6 Discussion
This paper proposes point and interval matching estimators for the average treatment effects and
the average treatment effects on the treated with multiple nominal treatments. This method is an
extension of the point and interval estimates developed by Abadie and Imbens [25, 33] for binary
treatment. Our derivations can also be used to obtain point and interval estimates for other linear
contrasts of the expectations of the potential outcomes.
Using simulations, we demonstrate that the basic and bias-corrected point estimates, in com-
bination with the newly proposed sampling variance estimate, result in statistically valid methods,
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Figure 2: Estimated average treatment effects and 95% confidence intervals comparing patients
receiving opioid treatment after MVC to patients receiving NSAID treatment, or concurrent opioid
and NSAID treatment
while a combination of these point estimates with randomization based sampling variance are gen-
erally invalid. The IPW and DR point estimates result in statistically valid methods for small b and
normally distributed covariates, but are generally invalid for large b and non-normally distributed
covariates. In addition, the newly proposed sampling variance estimates approximate the empirical
sampling variance well.
The simulation study used m = 1 and J = 1 for all configurations because improvements in
precision from using larger m and J are generally minimal in large samples, and can potentially
increase covariates’ bias [37]. An area for future work would be to identify m and J with optimal
operating characteristics. Another possible extension is to develop the point and interval estimates
for binary and count outcomes. Lastly, an important area of future research is to evaluate the
performance of matching estimators when the dimension of X is high or when there are many
treatments.
In conclusion, we propose inference methods for matching procedures to test the global null
hypothesis of no difference between treatments, as well as estimate pairwise treatment effects with
multiple treatments that are generally valid, accurate, and precise. These inference methods can
be easily adjusted to estimate average differences from a control and the overall mean.
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